SUSQUEHANNA INTERNATIONAL GROUP, LLP - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 70 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$112,000
+387.0%
87,205
+304.9%
0.00%
Q3 2019$23,000
-98.4%
21,536
-97.4%
0.00%
Q2 2019$1,420,000
+325.1%
835,513
+742.6%
0.00%
Q1 2019$334,000
+62.1%
99,159
+40.9%
0.00%
Q4 2018$206,000
-76.0%
70,378
-49.6%
0.00%
Q3 2018$860,000
-57.8%
139,600
-49.4%
0.00%
Q2 2018$2,037,000
-13.2%
276,076
-22.8%
0.00%
Q1 2018$2,346,000
-46.5%
357,580
-31.4%
0.00%
-100.0%
Q4 2017$4,382,000
-28.2%
521,031
-1.4%
0.00%
-50.0%
Q3 2017$6,104,000
+18.9%
528,493
+20.3%
0.00%0.0%
Q2 2017$5,133,000
-3.1%
439,474
+2.3%
0.00%
-33.3%
Q1 2017$5,299,000
+171.3%
429,462
+199.5%
0.00%
+200.0%
Q4 2016$1,953,000
-5.5%
143,404
+38.0%
0.00%0.0%
Q3 2016$2,067,000
+187.9%
103,902
+87.5%
0.00%
Q2 2016$718,000
-45.9%
55,400
-61.0%
0.00%
Q1 2016$1,327,000
-51.5%
142,008
+5.3%
0.00%
-100.0%
Q4 2015$2,734,000
-20.9%
134,872
-43.3%
0.00%0.0%
Q3 2015$3,456,000
-3.2%
237,900
+41.7%
0.00%0.0%
Q2 2015$3,572,000
+221.5%
167,927
+250.5%
0.00%
Q1 2015$1,111,00047,9160.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders